Full-Time

Clinical Success Manager

Radmachine Therapy

Confirmed live in the last 24 hours

Radformation

Radformation

51-200 employees

Healthcare software for radiation therapy planning

AI & Machine Learning
Healthcare

Compensation Overview

$130k - $150kAnnually

Junior, Mid

Remote in USA

Category
Customer Success
Customer Success & Support
Requirements
  • Minimum 2 years of experience in performing and analyzing daily, monthly, and annual radiation oncology machine QA
  • 2 years experience as a medical physics assistant or similar
  • Strong critical thinking skills
  • Exceptional presentation skills
  • Positive attitude and a passion for excellence in patient care
Responsibilities
  • Demo, install, and train clinics on Radformation’s RadMachine automated machine QA software
  • Implement RadMachine at clinics by developing QA templates and customizing clinics’ settings
  • Work with clinics to understand their issues and provide a solution independently and/or with the help of the programming team
  • Work with the sales team to demonstrate software to prospective customers and provide training to newly installed clinics
  • Proactively check in with current customers to hear feedback and share new features
  • Host webinars to answer clinics’ questions and highlight features
  • Test new versions of the software to aid in development and quality assurance
  • Develop training materials to distribute to clinics
  • Research new QA guidelines and staying current as updates are released
  • On-site visits to clinics when permitted

Radformation provides software tools that improve the treatment planning process for radiation therapy in healthcare. Their products, which are FDA-cleared, include ClearCheck for automating plan checks, ClearCalc for independent dose validation, EZFluence for creating 3D treatment plans, AutoContour for AI-driven contouring, ChartCheck for monitoring patient data in real-time, and QuickCode for billing quality assurance. These tools are designed to integrate smoothly into existing workflows at clinics and healthcare facilities. Radformation stands out from competitors by focusing on automation to enhance efficiency and accuracy in treatment planning, ultimately helping clinics save time and resources while maintaining high standards of patient care. The company's goal is to streamline the radiation therapy process, ensuring that healthcare providers can deliver effective treatment to patients.

Company Stage

Seed

Total Funding

$8.9M

Headquarters

New York City, New York

Founded

2016

Growth & Insights
Headcount

6 month growth

7%

1 year growth

71%

2 year growth

78%
Simplify Jobs

Simplify's Take

What believers are saying

  • The strategic partnership with Icon Group positions Radformation to significantly impact global cancer care through innovative workflows and advanced software solutions.
  • Regulatory clearances in multiple countries open up new markets, potentially leading to increased revenue and global influence.
  • The acquisition of Limbus AI and partnerships with companies like BVP Forge indicate a strong focus on innovation and continuous improvement in AI-driven cancer care solutions.

What critics are saying

  • The integration of Limbus AI's technology may present challenges in terms of compatibility and seamless operation within Radformation's existing systems.
  • The highly competitive nature of the healthcare technology sector means that Radformation must continuously innovate to maintain its market position.

What makes Radformation unique

  • Radformation's acquisition of Limbus AI enhances its AI-driven capabilities, setting it apart in the radiation oncology software market.
  • The company's focus on automation solutions for cancer care, such as AutoContour, significantly reduces treatment planning time, offering a clear advantage over traditional methods.
  • Radformation's global regulatory clearances in countries like Australia, Brazil, Canada, and Thailand demonstrate its commitment to meeting rigorous standards and expanding its international footprint.

Help us improve and share your feedback! Did you find this helpful?